Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.8120
+0.0270 (3.44%)
At close: May 2, 2025, 4:00 PM
0.8300
+0.0180 (2.22%)
After-hours: May 2, 2025, 6:41 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $13.55 million as of May 2, 2025.
Market Cap
13.55M
Enterprise Value
12.30M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $13.55M, a decrease of -59.40%. That is a compound annual growth rate of -76.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2025 | 13.10M | -32.89% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.62B |
| Johnson & Johnson | 373.98B |
| UnitedHealth Group | 363.33B |
| AbbVie | 348.51B |
| Novo Nordisk | 298.09B |
| Abbott Laboratories | 229.40B |
| Novartis AG | 223.05B |
| AstraZeneca | 218.59B |